Integrated in silico and in vitro approaches identify a HSP90 drug vulnerability axis in t(7;12) infant leukemia stem-like cells
Ylenia Cicirò, Denise Ragusa, Emily M. Johnson, Ayona Johns, Sina Kanannejad, Remisha Gurung, Macarena Oporto Espuelas, Chun-Wai Wade Suen, Gabriel Torregrosa-Cortés, Alice Giustacchini, Sabrina Tosi, Cristina Pina
The paper identifies HSP90 inhibitors as potential therapies for t(7;12)-AML by combining computational drug screening with in vitro experiments.
bioRxiv · Sep 6, 2025 · PreprintCancer Biology